AURKB as a target in non-small cell lung cancer with acquired resistance to anti-EGFR therapy von Bertran-Alamillo, Jordi, Cattan, Valérie, Schoumacher, Marie, Codony-Servat, Jordi, Giménez-Capitán, Ana, Cantero, Frédérique, Burbridge, Mike, Rodríguez, Sonia, Teixidó, Cristina, Roman, Ruth, Castellví, Josep, García-Román, Silvia, Codony-Servat, Carles, Viteri, Santiago, Cardona, Andrés-Felipe, Karachaliou, Niki, Rosell, Rafael, Molina-Vila, Miguel-Angel

Volltext

Vaccine antibodies against a synthetic epidermal growth factor variant enhance the antitumor effects of inhibitors targeting the MAPK/ERK and PI3K/Akt pathways von García-Roman, Silvia, Garzón-Ibáñez, Mónica, Bertrán-Alamillo, Jordi, Jordana-Ariza, Núria, Giménez-Capitán, Ana, García-Peláez, Beatriz, Vives-Usano, Marta, Codony-Servat, Jordi, d'Hondt, Erik, Rosell, Rafael, Molina-Vila, Miguel Ángel

Volltext

Anti-epidermal growth factor vaccine antibodies increase the antitumor activity of kinase inhibitors in ALK and RET rearranged lung cancer cells von Codony-Servat, Jordi, García-Roman, Silvia, Molina-Vila, Miguel Ángel, Bertran-Alamillo, Jordi, Viteri, Santiago, d'Hondt, Erik, Rosell, Rafael

Volltext

Pharmacogenomics in the treatment of lung cancer: an update von Morales-Espinosa, Daniela, García-Román, Silvia, Karachaliou, Niki, Rosell, Rafael

Volltext

Overcoming MET-mediated resistance in oncogene-driven NSCLC von Reischmann, Nadine, Schmelas, Carolin, Molina-Vila, Miguel Ángel, Jordana-Ariza, Núria, Kuntze, Daniel, García-Roman, Silvia, Simard, Manon A., Musch, Doreen, Esdar, Christina, Albers, Joachim, Karachaliou, Niki

Volltext

Anti–Epidermal Growth Factor Vaccine Antibodies Enhance the Efficacy of Tyrosine Kinase Inhibitors and Delay the Emergence of Resistance in EGFR Mutant Lung Cancer Cells von Codony-Servat, Jordi, García-Roman, Silvia, Molina-Vila, Miguel Ángel, Bertran-Alamillo, Jordi, Giménez-Capitán, Ana, Viteri, Santiago, Cardona, Andrés F, D’Hondt, Erik, Karachaliou, Niki, Rosell, Rafael

Volltext

Immunotherapy meets targeted therapy: will this team end the war against cancer? von Morales-Espinosa, Daniela, García-Román, Silvia, Teixidó, Cristina, Karachaliou, Niki, Rosell, Rafael

Volltext

Prospective analysis of liquid biopsies of advanced non-small cell lung cancer patients after progression to targeted therapies using GeneReader NGS platform von Mayo de Las Casas, Clara, Garzón-Ibañez, Mónica, Jordana-Ariza, Núria, Viteri-Ramírez, Santiago, Moya-Horno, Irene, Karachaliou, Niki, Yeste, Zaira, Campos, Raquel, Villatoro, Sergi, Balada-Bel, Ariadna, García-Peláez, Beatriz, Reguart, Noemí, Teixidó, Cristina, Jantús, Eloisa, Calabuig, Silvia, Aguado, Cristina, Giménez-Capitán, Ana, Román-Lladó, Ruth, Pérez-Rosado, Ana, Catalán, Maria José, Bertrán-Alamillo, Jordi, García-Román, Silvia, Rodriguez, Sonia, Alonso, Lidia, Aldeguer, Erika, Martínez-Bueno, Alejandro, González-Cao, Maria, Aguilar Hernandez, Andrés, Garcia-Mosquera, Juan, de Los Llanos Gil, Maria, Fernandez, Manuel, Rosell, Rafael, Molina-Vila, Miguel Ángel

Volltext

Abstract 951: Evolution of antibody titers, growth factor levels and in vitro activity in the sera of patients enrolled in the EPICAL trial of afatinib combined with anti-EGF vacci... von Garcia-Roman, Silvia, Codony, Jordi, Molina-Vila, Miguel Angel, Jordana-Ariza, Nuria, Garcia, Beatriz, Garzon, Monica, de las Casas, Clara Mayo, Catalan, Maria Jose, Aguilar, Andres, Viteri, Santiago, Cardona, Andres F., Rodríguez, Delvys, Cobo, Manuel, Reguart, Noemi, d'Hondt, Erik, Rosell, Rafael

Volltext

Abstract 290: Comparison of clinically relevant fusions detection using two multiplexing RNA based platforms: nCounter and GeneReader von Ibañez, Mónica Garzón, Gimenez-Capitán, Ana, Usano, Marta Vives, Lladó, Ruth Román, Rodriguez, Sonia, Aldeguer, Erika, Pelaez, Beatriz García, Ariza, Nuria Jordana, Aguado, Cristina, Viteri, Santiago, Aguilar, Andrés, Moya, Irene, Cabrera, Carlos, Catalán, Maria Jose, cao, Maria Gonzalez, Garcia-Roman, Silvia, Alamillo, Jordi Bertran, Casabal, Florencia Garcia, Rosell, Rafael, Molina-Vila, Miguel Angel, De Las Casas, Clara De La Caridad Mayo

Volltext

Abstract 6645: Anti-EGF antibodies significantly improve the activity of RET , BRAF , MEK and PI3K kinase inhibitors in preclinical models von Roman, Silvia Garcia, Servat, Jordi Codony, Vila, Miguel Angel Molina, Alamillo, Jordi Bertran, Garzon, Monica, Bueno, Alejandro Martínez, Viteri, Santiago, Cao, María González, Aguilar, Andrés, García, Juan José, d'Hondt, Erik, Rosell, Rafael

Volltext

Abstract 338: Anti-EGF antibodies significantly improve the activity of BRAF and KRAS inhibitors in preclinical models von Garcia-Roman, Silvia, Molina-Vila, Miguel A., d'Hondt, Erik, Rosell, Rafael

Volltext

Abstract 837: Antitumor effects of anti-EGF antibodies generated by vaccination in NSCLC tumor cells von Garcia-Roman, Silvia, Codony-Servat, Jordi, Molina-Vila, Miguel Angel, Bertran-Alamillo, Jordi, Gimenez-Capitán, Ana, Karachaliou, Niki, d'Hondt, Erik, Rosell, Rafael

Volltext

Abstract 1450: Anti-EGF antibodies generated by vaccination significantly improve the activity of kinase inhibitors in preclinical models von Codony-Servat, Jordi, Garcia-Roman, Silvia, Molina-Vila, Miguel Ángel, Bertran-Alamillo, Jordi, Giménez-Capitán, Ana, Viteri, Santiago, Cardona, Andrés F., Rodríguez, Delvys, Cobo, Manuel, Reguart, Noemi, Karachaliou, Niki, d'Hondt, Erik, Rosell, Rafael

Volltext

Abstract 4802: PB1, a DDR2 inhibitor with antitumor activity in preclinical models of squamous cell carcinoma and KRAS-mutated adenocarcinoma of the lung von Garcia-Roman, Silvia, Molina, Miguel Angel, Borrell, José Ignacio, Puig de la Bellacasa, Raimon, Morales, Daniela, Bertran, Jordi, Gimenez, Ana, Karachaliou, Niki, Rosell, Rafael

Volltext

Analysis of gene expression in the re-replication pathway and selective blockade with checkpoint inhibitors as a potential therapeutic option in NSCLC von Morales-Espinosa, Daniela, Molina-Vila, Miguel Angel, Gimenez Capitan, Ana, Garcia-Roman, Silvia, Bertran-Alamillo, Jordi, Mendez, Pedro, Ramirez-Serrano, Jose Luis, Codony, Carles, Viteri Ramirez, Santiago, Karachaliou, Niki, Rosell, Rafael

Volltext

A critical question for cancer therapy: what new targets exist? von Rosell, Rafael, Karachaliou, Niki, Codony, Jordi, Teixido, Cristina, Garcia-Roman, Silvia, Morales, Daniela, Cao, María González, Viteri, Santiago, Veliz, Ignacio, Loo, Yong, Castillo, Omar

Volltext

Abstract C006: BID upregulation associates with sensitivity to TTK inhibitors in tumor cell lines von Bertran-Alamillo, Jordi, Giménez-Capitán, Ana, García-Román, Silvia, Rosell, Rafael, Molina-Vila, Miguel A

Volltext

Clinical utility of body fluids for multiplexed detection of genetic alterations in cancer patients von Beatriz García, Beatriz, García-Román, Silvia, Román, Ruth, Aguado, Cristina, Garzón, Mónica, Aguilar, Andrés, Muñoz, Susana, Rosell, Rafael, Angel Molina- Vila, Miguel, Mayo de las Casas, Clara

Volltext

Abstract 3175: Copy number gains of clinically relevant genes in advanced non small cell lung cancer patients von Ariza, Núria Jordana, Garzón, Mónica, García-Peláez, Beatriz, Román, Ruth, Alamillo, Jordi Bertrán-, Rodriguez, Sonia, Aldeguer, Erika, García-Román, Silvia, Viteri, Santiago, Aguilar, Andrés, Cao, María González, Bueno, Alejandro Martínez, Vila, Miguel Angel Molina, Costa, Rafael Rosell, de las Casas, Clara Mayo

Volltext